Barriers to clinical trial enrollment

Part I of a two-part series

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

According to the National Cancer Institute (NCI), 1,735,350 people were newly diagnosed with cancer in 2018. Of those, 65% are expected to achieve remission from their cancer 1.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

Despite steady progress in reducing overall cancer mortality rates, cancer incidence in women is rising, according to the American Cancer Society’s “Cancer Statistics, 2025” report. Incidence rates in women 50-64 years of age have surpassed those in men, and rates in women under 50 are now 82% higher than their male counterparts, up from 51% higher in 2002. In 2021, for the first time, lung cancer incidence was higher in women under 65 than in men. 
Over the past five years, Cedars-Sinai Cancer has built an integrated, regional system designed to provide cancer care close to where patients live and work. This model of care, directed by an academic medical center to patients at the community level, proved to be the best possible approach to supporting patients in our 11-million-person catchment area during the worst fire disaster in California history. 
Daniel Wall, BSc
Research administrator, Marshfield Clinic
Stephanie Engelien, RN, MSN
Oncology research nurse, Marshfield Clinic
Adedayo A. Onitilo, MD, PhD, MSCR, FACP
Director, Oncology/Hematology
and Radiation Oncology Service Line; Department chair, Oncology/Hematology, Marshfield Clinic

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login